Background: Psoriasis is an immune-mediated, chronic inflammatory disease affecting multiple aspects of patients' lives. Its epidemiology varies regionally; however, nationwide epidemiologic data on psoriasis depicting profile of Korean patients has not been available to date. Objective: To understand nationwide epidemiologic characteristics and clinical features of adult patients with psoriasis visited university hospitals in Korea. Methods: This multicenter, non-interventional, cross-sectional study recruited 1,278 adult patients with psoriasis across 25 centers in Korea in 2013. Various clinical data including PASI, BSA, DLQI, SF-36 and PASE were collected. Results: A total of 1,260 patients completed the study (male:female=1.47:1). The mean age was 47.0 years with a distribution mostly in the 50s (24.9%). Early onset (＜40 years) of psoriasis accounted for 53.9% of patients. The mean disease duration was 109.2 months; mean body mass index was 23.9 kg/m 2 ; and 12.7% of patients had a family history of psoriasis. Plaque and guttate types of psoriasis accounted for 85.8% and 8.4%, respectively. Patients with PASI ≥10 accounted for 24.9%; patients with body surface area ≥10 were 45.9%. Patients with DLQI ≥6 accounted for 78.8%. Between PASI ＜10 and PASI ≥10 groups, significant difference was noted in age at diagnosis, disease duration, blood pressure, waist circumference of female, and treatment experiences with phototherapy, systemic agents, and biologics. Conclusion: This was the first nationwide epidemiologic study of patients with psoriasis in Korea and provides an overview of the epidemio-
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INTRODUCTION
Psoriasis is an immune-mediated, chronic inflammatory disease affecting various aspects of patients' lives far beyond the skin and challenging clinicians in its management 1 . While psoriasis is prevailing worldwide, there are regional differences in its epidemiological characteristics. Local differences in genetic, environmental, cultural, and geographic characteristics may be related. Although outstanding progress have achieved in various fields of psoriasis research, understanding epidemiologic profiles of the disease is still important. A more elaborate understanding of regional epidemiology is essential to refining the management of psoriasis. Unlike many western countries, where data from many large-scale epidemiologic studies are available, epidemiologic study data of nationwide scale were unavailable in Korea. In 2013, the Korean Society for Psoriasis (KSP) conducted a cross-sectional, multicenter study to delineate the clinical profile of adult patients with psoriasis visiting university hospitals in Korea. Here we report the results of this study.
MATERIALS AND METHODS

Study design
This was a multicenter, non-interventional, cross-sectional study. Patients were recruited for approximately 4 months, from February to June 2013. The 25 centers participating in the study were mainly university hospitals, located across the country (with the exception of the Jeju island region). This study was reviewed and approved by the Institutional Review Board of each center. To extract a representative sample reflecting the distribution of psoriasis in Korea, numbers and locations of study centers were selected on the basis of population distribution and health insurance reimbursement data of the patients with psoriasis in Korea. Because half of the total population of Korea lives near the capital, 13 of 25 centers were selected from the capital area. To avoid selection bias, study patients were examined and enrolled consecutively by visiting orders. After obtaining informed consent, all procedures of the study were performed on 1 day. 
Statistical analysis
Descriptive statistics for continuous variables are presented as means with standard deviation, and dichotomous variables are presented as frequencies with percentages in parentheses. Types of psoriasis, location of involved lesions, and clinical/demographic characteristics were compared to assess the statistical significance of any differences among the groups by disease severity (PASI ＜10, PASI ≥10). We used, where appropriate, the Wilcoxon rank-sum and t tests for continuous variables, and analyses for dichotomous variables that were based on Pearson's chi-square test and Fisher's exact test, without missing data imputation. In addition, a multiple logistic regression analysis was used to assess the adjusted effect of characteristics on PASI ≥10. Multicollinearity between independent variables had been checked by computing correlation coefficient and variance inflation factors (VIF) before the variables to be included in the regression model were selected. All statistical tests were performed using two-sided and p-values less than 0.05 were considered statistically significant. Analyses were performed using the statistical software package SAS 9.2 (SAS Institute, Cary, NC, USA). Values are presented as total number only, number (%), or mean±standard deviation. Total number does not always represent 100% of the study population because of missing values. Percentages of subgroup (by gender) were based on the total number of subjects in each PASI group per subgroup. PASI: psoriasis area and severity index, BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure. *p-value＜0.05.
RESULTS
Demographics
A total of 1,278 patients were enrolled in the study, and 1,260 (98.6%) completed the study. Eighteen patients (1.4%) were excluded from analysis, 16 (1.3%) for violation of the inclusion/exclusion criteria, and two (0.2%) for lack of data for the primary assessment. Demographic data from the 1,260 patients are presented in Table 1 . A total of 749 patients (59.4%) were male and 511 (40.6%) were female; the male to female ratio was 1.47:1. The mean age of the study patients was 47.0±14.5 years (range, 20∼89 years). Most study patients were in their 50s (24.9%), with a gradual increase from 20s to 50s and a sharp decrease after 60s. Table 2 ).
Location of lesions
Psoriasis lesions were most frequently found in the lower leg (72.6%, n=913), followed by the back (60.9%, n=766), upper leg (60.8%, n=764), elbow (58.0%, n=729), knee (57.1%, n=718), lower arm (56.8%, n=714), abdomen (55.7%, n=700), upper arm (53.5%, n=672), and scalp Values are presented as number (%). (53.1%, n=668). Nail involvement was noted in 12.3% of patients and genitalia involvement in 8.8% of patients. Details of lesion location are listed in Table 3 .
Disease severity
Of the total study patients, 75.1% (n=946) had PASI ＜10 and 24.9% (n=314) scored PASI ≥10 (19.0% had 10≤ PASI＜20, 5.9% had PASI ≥20). The mean PASI score was 7.5±7.1. The mean BSA (%) measurement was 13.1±14.6. 54.1% (n=681) of the total patients had BSA ＜10, 45.9% (n=577) had BSA ≥10 (14.3% had BSA ＜3%, 39.8% had 3≤BSA＜10, 25.4% had 10≤BSA ＜20, and 20.4% had BSA ≥20). On the other hand, with regards to the DLQI, results showed that of the 1,256 study patients whose DLQI data were available, 21.2% (n=266) scored DLQI ≤5 (no/small effect), 24.7% (n=310) scored 6≤DLQI≤10 (moderate effect), and 54.1% (n=680) scored DLQI ≥11 (very/extremely large effect). The mean value of DLQI was 12.0±7.2 (Fig. 2) . The mean SF-36 results were 48.8±8.0 for the physical component summary score and 42.6±11.2 for the mental component summary score (data not shown). PASE data were available for 1,255 patients. The mean PASE score was 33.7±13.1; 301 (24.0%) patients had a PASE score of 44 points or higher (Fig. 3 ).
Past and concomitant therapies
Of all past therapies utilized by the study patients (n=1,260), topical agents were the most common (93.6%, n=1,179), followed by systemic agents (61.2%, n=771), phototherapy (50.8%, n=640), and biologics (5.7%, n=72). The order of current therapy maintained at the time of enrollment was topical agent (86.0%, n=1,083), oral systemic agents (45.9%, n=578), phototherapy (30.6%, n=385), and biologics (4.6%, n=58). Although herbal medicine was used at some point by a considerable number of patients, it was seldom maintained ( Table 4) .
Comparison of factors related to disease based on disease severity
The patients were divided into two groups of PASI ＜10 and PASI ≥10 and factors that could be related with disease severity were compared. Gender, age, family history, height and weight, smoking/drinking history, and male gender's waist circumference and BMI did not showed any significant difference between two groups. However, there was significant difference between two groups regarding BMI in female, age at diagnosis, disease duration, waist circumference of female, blood pressure. The group with PASI ≥10 had longer disease duration (p=0.003) and earlier age of diagnosis (p=0.008) than the group with PASI ＜10 and comprised a significantly higher proportion of patients with systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg (p=0.001). BMI in female was significantly higher (p=0.046) and the proportion of waist circumference with ≥80 cm in female was higher in PASI ≥10 group (p=0.003, Table 1 ). Most of body parts were involved more as disease severity increased except for palm, sole (Table 3) . After adjusting for variables in demographic characteristics except age at diagnosis, height and weight due to multicollinearity, younger age, longer disease duration, absence of family history, longer waist circumference and higher blood pressure were significantly associated with severe disease (PASI ≥ 10, Table 5 ). More patients with PASI ≥10 had experienced treatment with phototherapy, systemic agents, and biologics compared to patients with PASI ＜10 (Table 4) .
Treatment satisfaction
Patients were divided into three treatment satisfaction groups: dissatisfied (from extremely dissatisfied to somewhat dissatisfied), neutral, or satisfied (from somewhat satisfied to extremely satisfied). The satisfied group included 733 patients (58.5%); neutral group, 317 (25.3%); and dissatisfied group, 202 (16.1%). In the PASI ＜10 group, satisfied proportion was significantly higher than the PASI ≥ 10 group (p=0.002, Table 6 ). Values are presented as number (%). PASI: psoriasis area and severity index, UV: ultraviolet, PUVA: psoralen and ultraviolet A. *p-value＜0.05.
DISCUSSION
Prior to this study, epidemiologic data for the patients with psoriasis in Korea were limited to small-scale or single-center studies using accumulated patient pools over long periods of time 3 . For this reason, it was difficult to obtain an overview of nationwide epidemiologic profile of psoriasis that is necessary for further research and better policy making for the patients with psoriasis in Korea. Hence, the KSP designed and conducted a nationwide . Unlike classical bimodal peaks in distribution patterns of age at diagnosis in western studies, which showed peaks located in the late teens and late 50s, Asian studies 4, 6 , including ours, showed dual peaks located in the 20s and 40s. Additionally, early-onset (type 1, ＜40 years) psoriasis accounted for more than 75% of patients in western studies 8 and 67.6% of patients in the Chinese study 6 , but only 53.9% in our study.
The prevalence of psoriasis has been reported to be equal between men and women in western studies [9] [10] [11] . However, in Asian studies 4, 5, 7, 12 , male predominance has been reported repeatedly. Our study also revealed the predominance of this disease in males (male to female ratio 1.47:1). This tendency was also noted in data from the Korean health insurance database in 2012 (1.36:1). But the degree of male predominance was somewhat lower than studies from other Asian countries such as Japan and Taiwan, which reported a male to female ratio of 1.6∼ 2.1:1 5, 7 . Although this phenomenon may be unique to the study population, the cause of this interesting observation needs to be elucidated. Although it is well known that obesity is closely related to psoriasis in western populations 8, 13, 14 It was difficult to compare the involved site with other published studies, as each uses different criteria to distinguish the location in the body. For future studies, it is necessary to define the boundary of anatomical regions in a standardized manner and use common protocol to express involved areas. Hernánz et al. 19 reported that patients with more severe psoriasis had greater skin involvement in most of area including the palms and soles. However, our data showed no significant differences in the involvement of palms and soles by disease severity divided by PASI score 10. When comparing disease severity as measured by PASI and BSA with quality of life as measured by DLQI, it was found that the impact of psoriasis on quality of life was not fully explained by the severity or extent of skin disease. Therefore, an independent assessment of quality of life should be considered in the management of psoriasis. Some studies 20, 21 reported a higher disease severity in male patients than in female patients. Although there was a higher proportion of males in the severe group, it was not statistically significant in our study (p=0.215).
Smoking has been known to be associated with the clinical severity of psoriasis 22 but the ratio of smoking history between two groups by disease severity did not differ statistically. Some studies have reported that patients with more severe disease had an earlier age of onset and a lon-ger disease duration 19, 23 . Those results are in line with our findings. The more severe group presented with significantly higher blood pressure, as reported by Cohen et al. 24 .
Interestingly, the patients with family history showed significantly milder disease severity than the patients without family history after adjusting for relevant demographic characteristics. Although there are some studies 25, 26 that family history is associated with early onset age, but it was difficult to find a study to explain a relationship between family history and disease severity. However, López-Estebaranz et al. 27 recently presented that the severity of psoriasis was not affected by the presence of a family history. Therefore, further studies are necessary to determine the association between family history and disease severity. Finally, it was remarkable that significantly more patients in the PASI ≥10 group were dissatisfied with treatment results than the PASI ＜10 group. This result indicates that more effective and satisfactory treatment is needed for patients with PASI ≥10.
Although we attempted to minimize the bias from regional and temporal factors and reveal multilateral aspects of the clinical profiles of Korean patients with psoriasis, due to the recruitment of adult patients mostly from university hospitals, the representation of the general psoriasis population in Korea is limited. Further, because this study was cross-sectional, it is necessary to use caution when interpreting results for causal relationships between disease-related factors and outcomes over time. Therefore, additional research in the form of prospective longitudinal cohort studies is needed to further understanding of psoriasis in the Korean population.
